Published in J Virol on June 01, 1996
Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A (1997) 6.09
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Subgenomic replicons of the flavivirus Kunjin: construction and applications. J Virol (1997) 3.92
Essential role of cyclization sequences in flavivirus RNA replication. J Virol (2001) 3.31
Infectious cDNA clone of the epidemic west nile virus from New York City. J Virol (2002) 3.21
Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. J Virol (2002) 2.62
In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc Natl Acad Sci U S A (1999) 2.56
Translation elongation factor-1 alpha interacts with the 3' stem-loop region of West Nile virus genomic RNA. J Virol (1997) 2.55
Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol (2005) 2.48
A 5' RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev (2006) 2.27
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
The relationships between West Nile and Kunjin viruses. Emerg Infect Dis (2001) 2.03
Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J Virol (2002) 1.98
Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol (1999) 1.94
Identification of specific nucleotide sequences within the conserved 3'-SL in the dengue type 2 virus genome required for replication. J Virol (1998) 1.88
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol (2005) 1.75
Vaccines: the fourth century. Clin Vaccine Immunol (2009) 1.61
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J Virol (2000) 1.56
RNA structures required for production of subgenomic flavivirus RNA. J Virol (2010) 1.52
Mutations in the 5' nontranslated region of bovine viral diarrhea virus result in altered growth characteristics. J Virol (2000) 1.51
A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. J Virol (2003) 1.50
An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1. J Virol (2010) 1.49
Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology (2006) 1.49
Authentic and chimeric full-length genomic cDNA clones of bovine viral diarrhea virus that yield infectious transcripts. J Virol (1997) 1.45
cis-acting RNA elements required for replication of bovine viral diarrhea virus-hepatitis C virus 5' nontranslated region chimeras. RNA (1998) 1.40
Dengue viruses - an overview. Infect Ecol Epidemiol (2013) 1.40
RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol (2006) 1.38
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine. Vaccine (2011) 1.36
Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication. J Virol (2004) 1.33
Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice. J Virol (2001) 1.33
Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes. J Virol (2002) 1.32
High-resolution functional profiling of hepatitis C virus genome. PLoS Pathog (2008) 1.30
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol (1996) 1.28
Structural and functional studies of the promoter element for dengue virus RNA replication. J Virol (2008) 1.27
The topology of bulges in the long stem of the flavivirus 3' stem-loop is a major determinant of RNA replication competence. J Virol (2005) 1.27
Transfection of HepG2 cells with infectious hepatitis C virus genome. Am J Pathol (1997) 1.23
Accumulation of a 3'-terminal genome fragment in Japanese encephalitis virus-infected mammalian and mosquito cells. J Virol (2004) 1.19
Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J Virol (2001) 1.19
Current progress in dengue vaccines. J Biomed Sci (2013) 1.16
Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. J Infect Dis (2013) 1.16
In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus. Antimicrob Agents Chemother (2007) 1.15
Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4. Vaccine (2007) 1.15
RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase. J Biol Chem (2010) 1.14
Functional RNA elements in the dengue virus genome. Viruses (2011) 1.11
Specific requirements for elements of the 5' and 3' terminal regions in flavivirus RNA synthesis and viral replication. Virology (2008) 1.11
NF90 binds the dengue virus RNA 3' terminus and is a positive regulator of dengue virus replication. PLoS One (2011) 1.08
Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06
Chikungunya virus 3' untranslated region: adaptation to mosquitoes and a population bottleneck as major evolutionary forces. PLoS Pathog (2013) 1.04
Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains. Virology (2008) 1.04
Mutation of mapped TIA-1/TIAR binding sites in the 3' terminal stem-loop of West Nile virus minus-strand RNA in an infectious clone negatively affects genomic RNA amplification. J Virol (2008) 1.02
Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys. J Virol (2002) 1.01
Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication. J Biol Chem (2011) 1.01
Novel dengue virus type 1 from travelers to Yap State, Micronesia. Emerg Infect Dis (2006) 1.00
Cellular proteins from human monocytes bind to dengue 4 virus minus-strand 3' untranslated region RNA. J Virol (2003) 0.94
Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis. Virology (2014) 0.93
Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice. J Virol (2003) 0.90
Essential and nonessential elements in the 3' nontranslated region of Bovine viral diarrhea virus. J Virol (2005) 0.90
Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet Vaccines Ther (2004) 0.89
A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication. RNA (2008) 0.89
RNA Structure Duplications and Flavivirus Host Adaptation. Trends Microbiol (2016) 0.89
Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone. J Virol (2001) 0.88
Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007. Int J Environ Res Public Health (2013) 0.87
Replication enhancer elements within the open reading frame of tick-borne encephalitis virus and their evolution within the Flavivirus genus. Nucleic Acids Res (2011) 0.87
Differential RNA sequence requirement for dengue virus replication in mosquito and mammalian cells. J Virol (2013) 0.86
Utility, limitations, and future of non-human primates for dengue research and vaccine development. Front Immunol (2014) 0.86
Issues related to recent dengue vaccine development. Trop Med Health (2011) 0.86
A novel single-dose dengue subunit vaccine induces memory immune responses. PLoS One (2011) 0.85
Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick-borne Langat virus does not alter vector specificity. J Gen Virol (2011) 0.85
Co-selection of West Nile virus nucleotides that confer resistance to an antisense oligomer while maintaining long-distance RNA/RNA base pairings. Virology (2008) 0.84
AUF1 p45 promotes West Nile virus replication by an RNA chaperone activity that supports cyclization of the viral genome. J Virol (2014) 0.83
Targeted mutagenesis as a rational approach to dengue virus vaccine development. Curr Top Microbiol Immunol (2010) 0.83
Molecular archaeology of Flaviviridae untranslated regions: duplicated RNA structures in the replication enhancer of flaviviruses and pestiviruses emerged via convergent evolution. PLoS One (2014) 0.83
Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4. Vaccine (2014) 0.82
Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice. PLoS One (2011) 0.81
Kissing-loop interaction between 5' and 3' ends of tick-borne Langat virus genome 'bridges the gap' between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: applications for virus attenuation and vaccine development. Nucleic Acids Res (2016) 0.81
High genetic stability of dengue virus propagated in MRC-5 cells as compared to the virus propagated in vero cells. PLoS One (2008) 0.80
Tackling dengue fever: Current status and challenges. Virol J (2015) 0.79
Genetic variation in the 3' untranslated region of dengue virus serotype 3 strains isolated from mosquitoes and humans in Brazil. Virol J (2013) 0.78
Replacement of conserved or variable sequences of the mosquito-borne dengue virus 3' UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes. J Gen Virol (2012) 0.77
Dengue vaccines: strongly sought but not a reality just yet. PLoS Pathog (2013) 0.77
Dengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeys. PLoS One (2014) 0.77
A Molecular Approach Designed to Limit the Replication of Mature DENV2 in Host Cells. Viral Immunol (2015) 0.75
Possible roles of new mutations shared by Asian and American Zika viruses. Mol Biol Evol (2017) 0.75
Functional Information Stored in the Conserved Structural RNA Domains of Flavivirus Genomes. Front Microbiol (2017) 0.75
Flavivirus genome organization, expression, and replication. Annu Rev Microbiol (1990) 14.20
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science (1985) 8.54
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology (1986) 3.85
Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol (1987) 3.30
Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci U S A (1991) 2.97
Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J Virol (1993) 2.65
The 3'-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology (1986) 2.50
Mutagenesis of the 3' nontranslated region of Sindbis virus RNA. J Virol (1990) 2.42
Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome. Virology (1995) 1.95
Experimental studies on dengue. I. Isolation, identification and modification of the virus. J Infect Dis (1952) 1.93
Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci U S A (1992) 1.89
Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity. J Virol (1987) 1.67
Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bull World Health Organ (1987) 1.57
Analysis of structural properties which possibly are characteristic for the 3'-terminal sequence of the genome RNA of flaviviruses. J Gen Virol (1986) 1.52
Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37
Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Arch Virol (1993) 1.36
Yield of infective ribonucleic acid from impure Murray Valley encephalitis virus after different treatments. Nature (1959) 1.35
Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol (1992) 1.34
Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus. J Virol (1992) 1.31
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol (1996) 1.28
Recent advances in our knowledge of dengue and sandfly fever. Am J Trop Med Hyg (1955) 1.28
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis (1984) 1.20
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J Infect Dis (1994) 1.19
Nucleotide sequence at the 3' end of Japanese encephalitis virus genomic RNA. Virology (1986) 1.18
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg (1984) 1.11
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans. Am J Trop Med Hyg (1990) 1.08
Experimental infection of New World monkeys with dengue and yellow fever viruses. Am J Trop Med Hyg (1958) 1.06
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. I. Pre-clinical studies. Am J Trop Med Hyg (1990) 0.90
Identification of RNA replicase subunits responsible for initiation of RNA synthesis of tick-borne encephalitis virus by affinity labelling. Biomed Sci (1991) 0.89
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol (1972) 9.12
Enzyme-linked immunosorbent assay (ELISA) for detection of human reovirus-like agent of infantile gastroenteritis. Lancet (1977) 7.84
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol (1969) 6.85
Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A (1995) 6.51
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13
Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell (1979) 6.03
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence. J Bacteriol (1968) 5.81
Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol (1966) 5.61
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Deletion mutants of simian virus 40 generated by enzymatic excision of DNA segments from the viral genome. J Mol Biol (1974) 5.47
Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. Science (1974) 5.32
Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci U S A (1971) 5.23
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Identification of simian virus 40 protein A. J Virol (1977) 4.93
Epitopes involved in antibody-mediated protection from Ebola virus. Science (2000) 4.92
A map of temperature-sensitive mutants of simian virus 40. Virology (1975) 4.77
The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol (1978) 4.73
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol (1991) 4.63
Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol (1973) 4.47
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Fatal food-induced anaphylaxis. JAMA (1988) 4.36
Mapping temperature-sensitive mutants of simian virus 40: rescue of mutants by fragments of viral DNA. Virology (1974) 4.30
Mapping the spliced and unspliced late lytic SV40 RNAs. Cell (1978) 4.25
Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A (1986) 4.14
Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology (1978) 4.08
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol (1971) 3.93
Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40. Proc Natl Acad Sci U S A (1979) 3.89
Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. J Infect Dis (1973) 3.89
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis (1971) 3.88
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology (1986) 3.85
Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol (1988) 3.84
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol (1973) 3.77
An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol (1966) 3.72
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol (1986) 3.64
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
New complement-fixation test for the human reovirus-like agent of infantile gastroenteritis. Nebraska calf diarrhea virus used as antigen. Lancet (1975) 3.56
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proc Natl Acad Sci U S A (1986) 3.53
Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med (1972) 3.51
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology (1987) 3.51
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol (1981) 3.46
Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol (1969) 3.39
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Growth of Mycoplasma pneumoniae on a glass surface. Ann N Y Acad Sci (1967) 3.31
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun (1982) 3.22
Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology (1987) 3.22
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci U S A (1991) 3.21
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Structure of an inducibly methylatable nucleotide sequence in 23S ribosomal ribonucleic acid from erythromycin-resistant Staphylococcus aureus. Biochemistry (1973) 3.19
A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol (1996) 3.18
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol (1981) 3.05
Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol (1989) 3.03
Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci U S A (1991) 2.97
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med (1972) 2.94
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A (1990) 2.90
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis (2000) 2.90
Place of death: preferences among cancer patients and their carers. Soc Sci Med (2004) 2.87
Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol (1985) 2.87
A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. Am J Epidemiol (1966) 2.81
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Processing and expression of early SV40 mRNA: a role for RNA conformation in splicing. Cell (1979) 2.80
Volatilisation of mercury and organomercurials determined by inducible R-factor systems in enteric bacteria. Nature (1974) 2.77
Antigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritis. Proc Soc Exp Biol Med (1976) 2.74
Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci U S A (1989) 2.74
Pattern of shedding of the Norwalk particle in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. J Infect Dis (1975) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am J Trop Med Hyg (2001) 2.67
Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay. Infect Immun (1978) 2.64
Escherichia coli mutants with altered control of alcohol dehydrogenase and nitrate reductase. J Bacteriol (1980) 2.61
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev (1997) 2.59
Proteins of Norwalk virus. J Virol (1981) 2.59
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study. Br J Ophthalmol (1997) 2.57
Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. Am J Epidemiol (1979) 2.56
Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus. J Mol Biol (1973) 2.51
Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol (1983) 2.50
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol (1986) 2.43